PENUMBRA INC (PEN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PEN - US70975L1070 - Common Stock
300.97 USD
-18.5 (-5.79%)
300.97 USD
0 (0%)
Overall PEN gets a fundamental rating of 6 out of 10. We evaluated PEN against 185 industry peers in the Health Care Equipment & Supplies industry. While PEN has a great health rating, its profitability is only average at the moment. PEN is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make PEN a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
PEN had positive earnings in the past year.
In the past year PEN had a positive cash flow from operations.
In multiple years PEN reported negative net income over the last 5 years.
In multiple years PEN reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of PEN (9.40%) is better than 91.89% of its industry peers.
PEN has a Return On Equity of 12.07%. This is amongst the best in the industry. PEN outperforms 88.65% of its industry peers.
PEN has a better Return On Invested Capital (7.37%) than 82.16% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PEN is significantly below the industry average of 8.84%.
The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.37%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROIC | 7.37% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PEN (12.30%) is better than 88.11% of its industry peers.
PEN's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 12.95%, PEN belongs to the top of the industry, outperforming 80.54% of the companies in the same industry.
In the last couple of years the Operating Margin of PEN has declined.
PEN has a Gross Margin of 66.80%. This is in the better half of the industry: PEN outperforms 70.81% of its industry peers.
In the last couple of years the Gross Margin of PEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% |
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PEN is destroying value.
PEN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PEN has been increased compared to 5 years ago.
The debt/assets ratio for PEN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 21.38 indicates that PEN is not in any danger for bankruptcy at the moment.
The Altman-Z score of PEN (21.38) is better than 95.68% of its industry peers.
The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.15, PEN belongs to the top of the industry, outperforming 93.51% of the companies in the same industry.
PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.02, PEN is doing good in the industry, outperforming 71.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Altman-Z | 21.38 |
ROIC/WACC0.74
WACC9.95%
2.3 Liquidity
PEN has a Current Ratio of 6.73. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN's Current ratio of 6.73 is amongst the best of the industry. PEN outperforms 85.41% of its industry peers.
A Quick Ratio of 4.18 indicates that PEN has no problem at all paying its short term obligations.
PEN has a Quick ratio of 4.18. This is in the better half of the industry: PEN outperforms 77.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.47%, which is quite impressive.
The Earnings Per Share has been growing by 24.23% on average over the past years. This is a very strong growth
The Revenue has grown by 14.61% in the past year. This is quite good.
The Revenue has been growing by 16.89% on average over the past years. This is quite good.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
3.2 Future
The Earnings Per Share is expected to grow by 24.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, PEN will show a quite strong growth in Revenue. The Revenue will grow by 13.24% on average per year.
EPS Next Y32.61%
EPS Next 2Y33.39%
EPS Next 3Y31.35%
EPS Next 5Y24.42%
Revenue Next Year15.96%
Revenue Next 2Y15.04%
Revenue Next 3Y14.52%
Revenue Next 5Y13.24%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PEN is valuated quite expensively with a Price/Earnings ratio of 82.91.
Compared to the rest of the industry, the Price/Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 65.95% of the companies listed in the same industry.
PEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.
The Price/Forward Earnings ratio is 58.94, which means the current valuation is very expensive for PEN.
Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than 67.57% of the companies in the same industry.
PEN is valuated expensively when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 82.91 | ||
| Fwd PE | 58.94 |
4.2 Price Multiples
PEN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PEN is cheaper than 64.86% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 70.81% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 77.22 | ||
| EV/EBITDA | 62.65 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PEN may justify a higher PE ratio.
PEN's earnings are expected to grow with 31.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.54
PEG (5Y)3.42
EPS Next 2Y33.39%
EPS Next 3Y31.35%
5. Dividend
5.1 Amount
PEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
300.97
-18.5 (-5.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.98%
Inst Owner Change1.07%
Ins Owners3.7%
Ins Owner Change3.13%
Market Cap11.79B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts85.83
Price Target338.37 (12.43%)
Short Float %4.29%
Short Ratio3.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)5.97%
PT rev (3m)6.13%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)-1.89%
EPS NY rev (1m)0.11%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 82.91 | ||
| Fwd PE | 58.94 | ||
| P/S | 8.84 | ||
| P/FCF | 77.22 | ||
| P/OCF | 57.98 | ||
| P/B | 8.67 | ||
| P/tB | 9.94 | ||
| EV/EBITDA | 62.65 |
EPS(TTM)3.63
EY1.21%
EPS(NY)5.11
Fwd EY1.7%
FCF(TTM)3.9
FCFY1.29%
OCF(TTM)5.19
OCFY1.72%
SpS34.06
BVpS34.7
TBVpS30.28
PEG (NY)2.54
PEG (5Y)3.42
Graham Number53.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROCE | 10.97% | ||
| ROIC | 7.37% | ||
| ROICexc | 10.5% | ||
| ROICexgc | 12.46% | ||
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% | ||
| FCFM | 11.44% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 291.22% | ||
| Cap/Sales | 3.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.89% | ||
| Profit Quality | 93.05% | ||
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 21.38 |
F-Score7
WACC9.95%
ROIC/WACC0.74
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y32.61%
EPS Next 2Y33.39%
EPS Next 3Y31.35%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year15.96%
Revenue Next 2Y15.04%
Revenue Next 3Y14.52%
Revenue Next 5Y13.24%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year81.21%
EBIT Next 3Y42.53%
EBIT Next 5Y26.5%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%
PENUMBRA INC / PEN FAQ
What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?
ChartMill assigns a fundamental rating of 6 / 10 to PEN.
What is the valuation status of PENUMBRA INC (PEN) stock?
ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.
Can you provide the profitability details for PENUMBRA INC?
PENUMBRA INC (PEN) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for PEN stock?
The Earnings per Share (EPS) of PENUMBRA INC (PEN) is expected to grow by 32.61% in the next year.